EGFR and gastric cancer: In previous studies, EGFR gene amplification has been reported to be present in only 2.3–4.9 % of gastric cancers including all histological subtypes [14–16], whereas the reported numbers for HER2 gene amplification vary between 7 and 17 % [17, 18].